Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunocompromised Host”

251 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 251 results

Not applicableStudy completedNCT00134342
What this trial is testing

Tuberculosis (TB) Screening for the Diagnosis of Latent TB in Immunocompromised Populations

Who this might be right for
Tuberculosis
University Health Network, Toronto 203
Not applicableNot Yet RecruitingNCT07603453
What this trial is testing

Performance of Clinical Metagenomics in Stool and Urine Samples for Unexplained Diseases Diagnostic and Emerging Diseases Surveillance in Immunocompromised Patients

Who this might be right for
Primary or Secondary Immune Deficiency Including Immunosuppressive Therapy, Chemotherapy, HIV Infection
Assistance Publique - Hôpitaux de Paris 120
Testing effectiveness (Phase 2)Study completedNCT05438602
What this trial is testing

Learn About the Study Medicines (Nirmatrelvir Plus Ritonavir) in People Aged 12 Years or Older With COVID-19 and a Compromised Immune System

Who this might be right for
COVID-19
Pfizer 158
Testing effectiveness (Phase 2)Study completedNCT00556998
What this trial is testing

A Multiple-Dose Study To Evaluate The Pharmacokinetics And Safety Of Voriconazole In Immunocompromised Adolescents

Who this might be right for
Pharmacokinetics
Pfizer 26
Large-scale testing (Phase 3)Study completedNCT05842967
What this trial is testing

Assess the Safety, Tolerability, and Immunogenicity of RSVpreF in Adults at High Risk of Severe RSV Disease

Who this might be right for
RESPIRATORY SYNCYTIAL VIRUS (RSV)
Pfizer 885
Not applicableStudy completedNCT00002132
What this trial is testing

Randomized, Controlled, Double-Blind Study of Itraconazole Oral Solution Versus Fluconazole Tablets for the Treatment of Esophageal Candidiasis.

Who this might be right for
Candidiasis, EsophagealHIV Infections
Janssen Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT00001757
What this trial is testing

An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections

Who this might be right for
Mycoses
National Institute of Allergy and Infectious Diseases (NIAID) 20
Not applicableLooking for participantsNCT07110636
What this trial is testing

Microbial Cell-free Metagenomic Sequencing for Suspected Infections in Adult Immunocompromised Outpatients

Who this might be right for
InfectionInfections, BacterialInfections, Fungal+2 more
Karius, Inc. 2,000
Not applicableUnknownNCT04395066
What this trial is testing

Molecular Diagnosis and Prognosis of Severe Pulmonary Infection Immunosuppressed Hosts

Who this might be right for
Severe PneumoniaImmunosuppressed HostsDiagnosis
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 171
Not applicableLooking for participantsNCT06752512
What this trial is testing

Remote Temperature Monitoring of Patients At Risk for Developing Fever

Who this might be right for
FeverCancerRemote Patient Monitoring
AION Biosystems 150
Not applicableStudy completedNCT00026767
What this trial is testing

Surveillance of Fungal Infections in Bone Marrow/Stem Cell and Organ Transplant Recipients

Who this might be right for
Fungus Disease
National Cancer Institute (NCI) 217
Not applicableStudy completedNCT03597269
What this trial is testing

Evaluation of Pneumococcal Vaccine Coverage

Who this might be right for
Immunocompromised Patients and Non-immunosuppressed Patients at Risk With an Indication for Pneumococcal Vaccination
Fondation Hôpital Saint-Joseph 80
Testing effectiveness (Phase 2)WithdrawnNCT01441024
What this trial is testing

DAS181 in Patients With Parainfluenza

Who this might be right for
Parainfluenza Infection
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Looking for participantsNCT06574789
What this trial is testing

Individualised Dose Optimisation of Ganciclovir in Immunocompromised Children Trial (ID-MAGIC)

Who this might be right for
Cytomegalovirus Viraemia
Murdoch Childrens Research Institute 232
Not applicableStudy completedNCT00008840
What this trial is testing

A Randomized, Open Label, Comparative, Multicenter Trial of Voriconazole Vs. AmBisome for Empirical Antifungal Therapy in Immunocompromised Patients With Persistent Fever and Neutropenia

Who this might be right for
Neutropenia
National Institute of Allergy and Infectious Diseases (NIAID) 866
Not applicableStudy completedNCT02016690
What this trial is testing

Synagis® Liquid 50mg, 100mg for Intramuscular Injection Special Investigation in Immunocompromised Children With Synagis®

Who this might be right for
Respiratory Syncytial Virus Infection
AbbVie 312
Not applicableLooking for participantsNCT07295535
What this trial is testing

Analysis of the Specificity and Persistence of Nasal Immune Responses to Respiratory Viral Antigens in Immunocompromised and Healthy Cohorts

Who this might be right for
Immuno-modulationImmuno-suppressionImmunocompromised Patients+2 more
Fondazione IRCCS Policlinico San Matteo di Pavia 40
Not applicableStudy completedNCT06738082
What this trial is testing

Influenza Vaccine Elicited Immune Response in Immunocompromised Patients

Who this might be right for
Influenza VaccineImmunocompromised Patients
Insel Gruppe AG, University Hospital Bern 147
Not applicableLooking for participantsNCT07321808
What this trial is testing

Immunogenicity, Efficacy and Safety of Recombinant Herpes Zoster Vaccine in Frail Patients

Who this might be right for
Immunocompromised Patients
Fondazione IRCCS Policlinico San Matteo di Pavia 300
Testing effectiveness (Phase 2)Looking for participantsNCT06599658
What this trial is testing

COVID-19 Booster and IIV Schedule in Immunocompromised Hosts

Who this might be right for
COVID 19InfluenzaRheumatoid Arthritis (RA)+5 more
McGill University Health Centre/Research Institute of the McGill University Health Centre 660
Next Page